3 results
Approved WMORecruiting
Study CA001-050 is a Phase 2 randomized, open label, multicenter clinical study designed to assess the safety and tolerability, of treatment with MS-986012 in combination with chemotherapy (carboplatin and etoposide) and nivolumab when administered…
Approved WMOWill not start
The objective of the study is to compare free-hand needle placement with navigation guided needle placement.
Approved WMOCompleted
To validate 18F-Flutemetamol PET in the evaluation of plaque vulnerability.